Overview

Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441

Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the safety of the concomitant administration of ACT-334441 with cardiovascular drugs.
Phase:
Phase 1
Details
Lead Sponsor:
Actelion
Idorsia Pharmaceuticals Ltd.
Treatments:
Atenolol
Calcium Channel Blockers
Diltiazem